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ABSTRACT The ALL-1 gene positioned at 11q23 is di-
rectly involved in human acute leukemia either through a
variety of chromosome translocations or by partial tandem
duplications. ALL-1 is the human homologue of Drosophila
trithorax which plays a critical role in maintaining proper
spatial and temporal expression of the Antennapedia-bithorax
homeotic genes determining the fruit f ly’s body pattern.
Utilizing specific antibodies, we found that the ALL-1 protein
distributes in cultured cells in a nuclear punctate pattern.
Several chimeric ALL-1 proteins encoded by products of the
chromosome translocations and expressed in transfected cells
showed similar speckles. Dissection of the ALL-1 protein
identified within its '1,100 N-terminal residues three
polypeptides directing nuclear localization and at least two
main domains conferring distribution in dots. The latter
spanned two short sequences conserved with TRITHORAX.
Enforced nuclear expression of other domains of ALL-1, such
as the PHD (zinc) fingers and the SET motif, resulted in
uniform nonpunctate patterns. This indicates that positioning
of the ALL-1 protein in subnuclear structures is mediated via
interactions of ALL-1 N-terminal elements. We suggest that
the speckles represent protein complexes which contain mul-
tiple copies of the ALL-1 protein and are positioned at ALL-1
target sites on the chromatin. Therefore, the role of the
N-terminal portion of ALL-1 is to direct the protein to its
target genes.
The ALL-1 gene located at 11q23 was cloned (1, 2) because of
its involvement in chromosome abnormalities occurring in
10% of patients with acute lymphocytic or myeloid leukemia,
in particular in infants and secondary leukemias (3). In some
of the patients, ALL-1 is undergoing partial tandem duplica-
tion (4), but in the majority of cases, ALL-1 recombines to a
partner gene to produce a chimeric protein (1, 2). The number
of partner genes is strikingly high—more than 25 are predicted
by cytogenetic evidence, and 10 were already cloned (reviewed
in refs. 5 and 6). The critical product of the translocations is
composed of the N-terminal 1,300–1,400 residues of ALL-1
fused in phase to the C-terminal segment of the open reading
frame of the partner genes. One such fusion product was shown
to induce acute leukemia in mice (7).
On the basis of sequence homology, it was originally sug-
gested (1, 2, 8) that ALL-1 is the human homologue of
Drosophila trithorax (trx). Subsequent studies involving gener-
ation of ALL1y2 knockout mice and of ALL-12y2 embryos,
and the identification of homeotic transformations in these
animals (9) proved this suggestion. In Drosophila, the activity
of the homeotic genes of the Antennapedia and bithorax
complexes determine the various body structures along the
anterior–posterior axis (10). Following the establishment of
expression pattern of these homeotic genes shortly after
fertilization by the segmentation genes, the state of determi-
nation has to be maintained during proliferation. The main-
tenance function is accomplished mainly by the genes of the
trithorax and Polycomb groups (trx-G and Pc-G), named after
their best known members (for reviews, see refs. 11 and 12).
Genetic and molecular data indicate that the trx-G and Pc-G
proteins act to trigger or inhibit transcription of their target
genes, respectively. Applying histochemical analysis, it was
found that the proteins encoded by several Pc-G genes show
almost identical binding patterns to up to 100 genes on
polytene chromosomes of salivary glands (13–15). The two
trx-G proteins, TRITHORAX (TRX) and ASH1, also bind to
polytene chromosomes at about 60 and 100 sites, respectively
(16–18). Many of these sites colocalize with those of the Pc-G
proteins. This suggests that trx-G and Pc-G proteins assemble
on the chromatin into activating or repressive transcriptional
complexes, respectively. Finally, it is thought that trx-GyPc-G
proteins act by remodeling chromatin. This is based on mo-
lecular similarities, as well as on physiological properties
shared by some trx-GyPc-G proteins with chromatin proteins
that act as modifiers of position effect variegation. Direct
biochemical evidence for chromatin alterations was recently
obtained for the yeastymammalian homologues of Drosophila
BRM–SWI2ySNF2. These proteins are included within the
SWIySNF complex, which acts to disrupt nucleosomes and
facilitates binding of transcription factors (19, 20). Similarly,
the trx-G protein TRL (GAGA) is a component of another
protein complex which remodels chromatin (21).
Two domains, the SET motif and PHD fingers, are highly
conserved between the ALL-1 and TRX proteins. These
domains are also found in some trx-GyPc-G and related
proteins, involved in embryonic development, and associated
with chromatin (14, 17, 22, 23). ALL-1 and TRX share several
additional short homologous regions (24–26). Finally, ALL-1
contains several unique motifs such as AT-hooks that are
thought to bind DNA, transcriptional transactivation domain
(TAD), and regions with homology to DNA methyltransferase
(mT) or U1 small nuclear ribonucleoprotein (snRNP) (5, 6,
27). Here, we show that specific domains within the N-terminal
portion of ALL-1 mediate speckled nuclear distribution of the
protein. The possible meaning of these speckles is discussed.
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MATERIALS AND METHODS
Plasmid Construction. Various restriction fragments of
ALL-1 cDNA were subcloned into pSG5 expression vector
(Stratagene) containing a FLAG-encoding sequence followed
by a stop codon. Junction sequences derived from patients with
leukemias carrying t(4:11), t(11:17), or t(9:11) abnormalities
were PCR-amplified and used to create pSG5 ALL-1yAF-4,
ALL-1yAF-17, or ALL-1yAF9yFLAG constructs.
An expression vector for chicken muscle pyruvate kinase
(PK), RLPK12, was described elsewhere (28, 29). We incor-
porated a FLAG peptide-encoding sequence at the C-terminal
end of the PK cDNA sequence (RLPK12–FLAG) so that the
ALL-1 polypeptides linked in-frame to PK could be identified
with mouse anti-FLAG mAb. Segments derived from ALL-1
cDNA were PCR-amplified or purified electrophoretically
after digestion of bigger fragments, and subcloned at XhoI and
EcoRI sites incorporated at the N terminus of the PK coding
sequence.
To create constructs with mutations or deletions, site-
directed mutagenesis was performed using Ex-site PCR-based
site-directed mutagenesis kit (Stratagene) with slight modifi-
cations.
Transfection and Immunostaining. COS, HeLa, or SV80
cells were grown in six-well culture dishes on 18-mm2 glass
coverslips in DMEM supplemented with 10% fetal bovine
serum for 16–30 hr to 80% confluency. For transfection, cells
were incubated with lipofectamine (GIBCOyBRL) containing
2 mg of plasmid DNA per well, according to the manufacturer’s
descriptions. Thirty-six hours after transfection, cells were
washed in PBS and fixed in methanol at 220°C for 10 min.
Fixed cells were incubated with normal blocking serum in a
humid chamber at room temperature and subsequently with
mouse anti-FLAG M2 mAb (Eastman Kodak), or with rabbit
anti-human ALL-1 antibody (Ab) (the P4 and P3 Ab were
raised against peptides spanning residues 1,281–1,299 and
153–167, respectively) at concentrations of 15 mgyml for 1 hr.
The cells were washed with PBS for 15 min and finally
incubated for 1 hr in a mixture containing TRITC (tetra-
methyl-rhodamin isothiocyanate)-conjugated goat anti-mouse
IgG (Jackson ImmunoResearch) diluted 1:300 and the DNA-
binding fluorescent dye DAPI (49,6-diamidino-2-phenylin-
dole; 1 mgyml). After a 15-min wash with PBS, cells were
embedded in elvanol and images of labeled cells were recorded
using Zeiss Axiophot fluorescent microscope with a Plan 3100
objective.
Electron Microscopy Analysis. Preparation of the samples
and immunolabeling were performed using modifications of
the Tokuyasu method as previously described (30). The cells
were fixed with 0.1% glutaraldehyde and 3% formaldehyde in
0.1 M cacodylate buffer (pH 7.2) for 1 hr. The cells were
washed in the buffer, scraped off the plate, and embedded in
10% gelatin. The gelatin blocks were postfixed as above for 16
hr, incubated in 2.3 M sucrose, and cryosectioned at 2120°C
using a Reichert FCS ultracryotome. The ultrathin sections
were collected on grids, washed in PBS, and blocked with 0.5%
BSA, 1% normal goat serum, 1% gelatin, 1% cystein, and 1%
Tween-20 in PBS. The sections were immunolabeled as indi-
cated above, embedded in methylcellulose, and examined with
a Philips model EM410 electron microscope at 80 kV.
RESULTS
Endogenous ALL-1 and Chimeric ALL-1 Proteins Show a
Speckled Nuclear Distribution. Utilizing two antipeptide Abs,
we detected the normal ALL-1 protein in the nucleus with no
significant staining in the cytoplasm (Fig. 1). The protein was
excluded from the nucleolus and showed a pattern of small
speckles uniformly distributed in the nucleoplasm. The same
pattern was observed in COS, HeLa, and SV80 cells, as well as
in a series of leukemic cell lines with or without 11q23
abnormalities. We now investigated the cellular distribution of
FIG. 1. Subcellular distribution in COS cells of endogenous ALL-1 and of transiently transfected chimeric ALL-1 proteins. FLAG-tagged
ALL-1yAF-9 was detected with anti-FLAG mAb. The other proteins were detected with polyclonal Ab P3 or P4 against ALL-1. Transfected cells
expressed at least 10-fold more exogenous protein compared with endogenous ALL-1.
FIG. 2. (A) Immunogold labeling of COS cells for endogenous
ALL-1 by using rabbit P4 Ab followed by gold (15 nm)-conjugated goat
anti rabbit IgG (Zymed). (342,500.) (B) Immunogold labeling of COS
cells transfected with FLAG-tagged ALL-1yAF-9 utilizing monoclo-
nal mouse antibody to the epitope and gold (10 nm)-conjugated goat
anti-mouse IgG (Zymed). (342,500.)
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chimeric ALL-1 proteins produced in acute leukemias with the
t(4:11), t(9:11), or t(11:17) abnormalities. The proteins were
transiently overexpressed in COS cells and detected by staining
with anti-ALL-1 polyclonal Ab. Being tagged with the FLAG
peptide, ALL-1yAF-9 was also detected with anti-FLAG mAb.
The three proteins showed nuclear punctate pattern (Fig. 1).
The pattern was less uniform than that of endogenous ALL-1,
and consisted of small dots and bigger patches. The proteins
were present within both the nucleoli and nucleoplasm and
sometimes at the nucleus’ periphery. The difference in distri-
bution of the endogenous and exogenous ALL-1 proteins
might be due to overexpression of the latters. Although
overexpressed truncated ALL-1 (amino acids 1–1,424) showed
a pattern comparable to that of the chimeric proteins (see
below), we cannot exclude some effects of the partner polypep-
tides on the distribution.
In an attempt to further localize the ALL-1 proteins, we
used electron microscopy (Fig. 2). The staining was predom-
inantly nuclear, mostly organized in the form of small clusters
with a typical diameter of about 1 micron. The exogenous
molecules often distributed as less homogenous clusters. The
labeling was rarely associated with nucleoli and was not
preferentially enriched near the lamina.
Identification of ALL-1 Elements Directing Nuclear Local-
ization. Segments of the ALL-1 protein were epitope-tagged
with the FLAG peptide. The constructs were inserted into the
expression vector pSG5 and transfected into COS cells, and the
FLAG-tagged proteins examined for subcellular distribution
(Fig. 3A). Fragments from the N terminus and the center of the
protein were found present in the nucleus and cytoplasm,
respectively. Fragments of the C terminus were found associ-
ated with the cytoplasm or with the entire cell. For further
confirmation andyor identification of ALL-1 fragments con-
ferring nuclear localization, we used the established method-
ology (28, 29) of linking in-frame small polypeptides of the
studied protein to the cytoplasmic enzyme PK and determin-
ing the subcellular distribution of the fused proteins (Fig. 3B).
Examples of this and the previous analysis are shown in Fig.
3C. The results indicate that ALL-1 N-terminal '820 residues
contain nuclear targeting sequences. Interestingly, the region
with homology to mT confers localization in cytoplasmic
speckles positioned at the periphery of the nucleus; no other
ALL-1 segment directed such a pattern.
The N-terminal region of ALL-1 was further dissected (Fig.
4) to identify three relatively small polypeptides, NTS-1,
NTS-2, and NTS-3 (NTS, nuclear targeting sequence) direct-
ing PK to the nucleus. NTS-1 was less efficient than the other
two, so that 10–15% of the staining was detected in the
cytoplasm. NTS-3 spans a classical nuclear targeting sequence,
RKRKRK, positioned at residues 734–739. We note that an
NTS-3 mutant with a deletion of the six basic amino acids
FIG. 3. Mapping nuclear targeting signals of ALL-1. Protein segments were linked to the FLAG tag, inserted into the pSG5 vector (A) or the
RLPK12 vector (B) and transiently transfected into COS cells. (C) Representative stained cells. AT and ZF correspond to AT hook and zinc finger
(PHD finger) domains, respectively.
FIG. 4. (A) Fine mapping of ALL-1 nuclear targeting signals. p,
Ninety percent of staining in nucleus; pp, about equal nuclear and
cytoplasm staining. (B) Typical patterns of cells expressing NTS-1, -2,
or -3.
7288 Cell Biology: Yano et al. Proc. Natl. Acad. Sci. USA 94 (1997)
(734–739) was incapable of nuclear targeting when tethered to
PK (data not shown).
Elements Mediating Punctate Pattern. Polypeptides con-
taining NTS-2 localized as nuclear speckles (Fig. 4B), remi-
niscent of endogenous and exogenous ALL-1 proteins. By
testing a series of constructs containing PK linked to small
segments of ALL-1, we determined two domains conferring
punctate distribution (Fig. 5A). SNL-1 (SNL, speckled nuclear
localization) co-maps with NTS-2. In contrast, SNL-2 did not
determine nuclear localization by itself, but once there
(through linking to NTS-3 or NTS-1) it would appear in
speckles. Remarkably, SNL-1 and SNL-2 spanned short ALL-1
domains (Trx in Fig. 5)—amino acids 388–432 and 1,051–
1,089, respectively—which are conserved with TRX (24, 25)
and are nearly identical in the latter and in the homologous
protein from Drosophilia virilis (25). Deletions of SNL-1 and
SNL-2 from the 59 and 39 halves of truncated ALL-1, respec-
tively, indeed resulted in nuclear nonpunctate distribution
(Fig. 5B). While SNL-1 and SNL-2 were the only domains
identified by the PK methodology, as domains conferring dots,
we found that cells expressing an ALL-1 N (amino acids
1–1,424) protein from which the two domains were deleted
(residues 322–480 and 1,034–1,115) still exhibited nuclear
speckles (Fig. 5B). Thus, other N-terminal determinants could
still confer a dot pattern. These determinants appear to be
included within residues 373–1,164 because deletion of the
segment abolished punctate distribution completely (Fig. 5B).
Deletion of amino acids 408–432 from the NTS-2ySNL-1
(amino acids 322–480)-PK construct resulted in a diffuse and
predominantly (80–90% of the staining) nuclear distribution
of the protein (Fig. 6A). An NTS-2ySNL-1-PK construct,
mutated at amino acids 418–423 (SSRIIK to AAAAAA),
which are fully conserved between ALL-1 and TRX, showed
an '60–70% decrease in the number of cells displaying a
punctate pattern, although the protein remained exclusively in
the nucleus (Fig. 6A). Moreover, PK constructs spanning
ALL-1 residues 322–407 or 433–480 distributed in the cyto-
plasm and predominantly in the nucleus, respectively (data not
shown). This indicates that within the NTS-2ySNL-1 region,
speckle formation is solely conferred by residues 408–432
conserved with TRX, while the major nuclear targeting activ-
ity is directed by amino acids 433–480. Fine deletiony
mutagenesis methodology was also applied to the SNL-2
domain (Fig. 6A). Deletion of the central TRX conserved
region (amino acids 1,065–1,089) from the SNL-2 (amino acids
1,034–1,115)-PK protein resulted in loss of the punctate
pattern. Alterations of the conserved residues 1,065–1,073
(GPRIKHVCR to AAAAAAAAA) reduced by '80% the
number of cells with dots.
The dichotomy between two ALL-1 elements directing
nuclear localization (NTS-1 and NTS-3) and an element
conferring punctate pattern (SNL-2) enabled us to investigate
whether other domains of the ALL-1 protein, derived from the
center and C terminus of the molecule, when artificially
expressed in the nucleus would distribute in speckles. Thus,
ALL-1 segments spanning either the polypeptide with homol-
ogy to mT, or the PHD fingers region, or the transcriptional
TAD, or the SET domain were fused to NTS-1 or NTS-3 and
examined for subnuclear distribution (Fig. 6B). None of these
segments directed a punctate pattern. This indicates that only
ALL-1 N-terminal elements are capable of interactions result-
ing in subnuclear foci distribution.
DISCUSSION
The two main findings reported here are the presence of the
ALL-1 protein in multiple large subnuclear structures and the
identification of several elements within the N-terminal one-
third of the molecule, responsible for nuclear localization
andyor distribution into speckles. Overexpressed leukemia-
associated chimeric ALL-1 proteins or overexpressed specific
ALL-1 segments were also present as nuclear dots. These dots
FIG. 5. ALL-1 segments conferring punctate nuclear pattern, inserted within the RLPK12 vector (A) or the pSG5 vector (B). pp, A minority
of cells show unusual, poorly defined patches. (C) Representative examples.
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were of various sizes, showed uneven distribution, and were
present in both nucleoplasm and nucleoli. Although the dif-
ferences in pattern between the endogenous and exogenous
molecules could be due to the partial nature of the exogenous
ALL-1 derivatives, we suspect that the variance is mainly due
to overexpression. Similarly, overexpression of the Bmi1 pro-
tein, also distributed in nuclear punctate pattern, led to an
increase in size of the speckles (31).
Other proteins were previously shown to distribute as nu-
clear foci. These include proteins of spliceosomes (32, 33);
lamins (34); proliferating cell nuclear antigen, which is present
at sites of DNA replication (35); PML (36, 37); and BRCA1
(38). However, the proteins most relevant to our finding are
Drosophila Polycomb (39), and Bmi1, Mel 18, Rae-28, and
M33, which are present in a mammalian Polycomb complex
(31). These five proteins are localized during interphase in
large immunologically visible nuclear dots excluded from
nucleoli.
We consider it likely that the dots associated with ALL-1
represent sites on the chromatin where ALL-1 is bound and
activates transcription of target genes. Similarly, we suggest
that the speckles involving Polycomb-related proteins corre-
spond to genes bound by these proteins and subsequently
repressed. To be seen as bright spots by immunofluorescence
staining, the ALL-1 protein must be localized in multiple
copies associated with the same gene or it has to be bound to
clustered adjacent genes. If indeed the dots represent target
genes for ALL-1, the large number (.100) of the dots in intact
COS cells indicates many targets. The presence of the dots in
a variety of cell lines, strongly suggests that ALL-1 function(s)
is not limited to embryos.
By linking an epitope-tagged PK to segments of the ALL-1
protein, we identified two domains (NTS-1, NTS-3) that direct
the fused protein to the nucleus, a domain (SNL-2) conferring
nuclear speckles, and a region (NTS-2ySNL-1) that both
localizes to the nucleus and induces dots’ formation. Within
this region, the central portion directs punctate pattern, and
the centralyC-terminal portions confer nuclear localization.
Remarkably, all these domains are present within the '1,100
N-terminal residues of the protein, and SNL-1 and -2 corre-
spond to sequences conserved with TRX. This suggests that
the N-terminal portion of ALL-1 directs the protein into the
nucleus and interacts (most efficiently, but not exclusively, via
SNL-1 and -2) with a protein complex that we propose to be
anchored to ALL-1 target genes. According to this model, and
in conjunction with the results depicted in Fig. 6, other
previously noted domains of ALL-1 such as SET, PHD fingers,
TAD, and the motif homologous to mT interact with cellular
components that are not included in the DNA-anchored
complex.
This division of functions between the N-terminal one-third
of the protein and the rest of the molecule might be reflected
in the fact that the former is the oncogenic part of ALL-1 (it
is rendered oncogenic by fusion to partner proteins or through
partial tandem duplication). We showed here that this part of
the protein is capable of being incorporated into subnuclear
structures. If the latter indeed represents normal target genes
of ALL-1, the chimeric protein could interfere with, or
enhance, the expression of these genes.
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FIG. 6. (A) SNL-1 and SNL-2 correspond to sequences conserved between ALL-1 and TRX. (B) Central and C-terminal segments of ALL-1,
enforced for nuclear expression, do not confer punctate pattern. p, A minority of cells show unusual, poorly defined patches.
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